HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhi Hong Selected Research

Zhi Hong Research Topics

Disease

12Infections
01/2019 - 01/2002
3Starvation
01/2023 - 01/2020
3Chronic Hepatitis B
04/2016 - 08/2003
3Hepatitis C
03/2014 - 10/2004
3Virus Diseases (Viral Diseases)
01/2006 - 09/2003
2Neoplasms (Cancer)
03/2024 - 03/2010
2Body Weight (Weight, Body)
10/2021 - 04/2002
2Tuberculosis (Tuberculoses)
08/2021 - 07/2020
2Burns
01/2017 - 01/2017
2Viremia
04/2016 - 01/2015
2Chronic Hepatitis C
07/2014 - 05/2003
2Dwarfism
07/2012 - 07/2012
2Hepatitis
02/2006 - 10/2002
2Diarrhea
01/2006 - 03/2005
2Hemolytic Anemia
06/2005 - 05/2003
1Type 2 Diabetes Mellitus (MODY)
10/2021
1Ischemic Stroke
06/2021
1Neuroinflammatory Diseases
06/2021
1Brain Injuries (Brain Injury)
06/2021
1Fibrosarcoma
06/2021
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2021
1Inflammation (Inflammations)
01/2020
1Colitis
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020
1Hypertension (High Blood Pressure)
07/2019
1Hyperaldosteronism (Conn Syndrome)
07/2019
1Obesity
07/2019
1Shock
01/2017
1Dehydration (Water Stress)
02/2015
1Breast Neoplasms (Breast Cancer)
03/2010

Drug/Important Bio-Agent (IBA)

6InterferonsIBA
04/2016 - 01/2002
6Ribavirin (Virazole)FDA LinkGeneric
06/2005 - 01/2002
4Glucose (Dextrose)FDA LinkGeneric
01/2023 - 01/2020
4Proteins (Proteins, Gene)FDA Link
01/2023 - 03/2014
4NucleosidesIBA
04/2016 - 01/2003
4Antiviral Agents (Antivirals)IBA
03/2005 - 10/2002
3CytokinesIBA
06/2021 - 01/2017
3cabotegravirIBA
01/2017 - 03/2014
3taribavirin (viramidine)IBA
06/2005 - 05/2003
2NitrogenIBA
01/2023 - 12/2020
2Autophagy-Related Protein-1 HomologIBA
01/2023 - 12/2020
2Green Fluorescent ProteinsIBA
01/2023 - 12/2020
2Phosphotransferases (Kinase)IBA
01/2023 - 03/2007
2AMP-Activated Protein KinasesIBA
01/2023 - 12/2020
2Oxidoreductases (Dehydrogenase)IBA
12/2020 - 01/2003
2T-DNAIBA
07/2012 - 07/2012
2NucleotidesIBA
11/2006 - 02/2006
2ProdrugsIBA
02/2006 - 11/2004
2Subgenomic RNAIBA
03/2005 - 11/2002
1Sirolimus (Rapamycin)FDA Link
01/2023
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2023
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
01/2023
1Class III Phosphatidylinositol 3-KinasesIBA
01/2023
1salicylhydroxamic acid (SHAM)IBA
10/2021
1Blood Glucose (Blood Sugar)IBA
10/2021
1AdipokinesIBA
10/2021
1Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
10/2021
1Isoniazid (Ftivazide)FDA LinkGeneric
08/2021
1TabletsIBA
08/2021
1Tight Junction ProteinsIBA
06/2021
1phthalide derivative CD21IBA
06/2021
1Evans Blue (Blue, Evans)FDA Link
06/2021
1Tissue Plasminogen Activator (Alteplase)FDA Link
06/2021
1Messenger RNA (mRNA)IBA
06/2021
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2021
1Scavenger Receptors (Scavenger Receptor)IBA
06/2021
1Toll-Like Receptor 4IBA
06/2021
1PeroxiredoxinsIBA
06/2021
1Claudin-5IBA
06/2021
1Mesylates (Mesylate)IBA
12/2020
1Myelin Basic ProteinIBA
12/2020
1methanesulfonic acid (methanesulfonate)IBA
12/2020
1MannosidasesIBA
12/2020
1AminopeptidasesIBA
12/2020
1Glyceraldehyde 3-Phosphate (Glyceraldehyde 3 Phosphate)IBA
12/2020
1Dextran SulfateIBA
01/2020
1Peroxidase (Myeloperoxidase)IBA
01/2020
1bilobalideIBA
01/2020
1Antihypertensive Agents (Antihypertensives)IBA
07/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1ChemokinesIBA
01/2017
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
01/2017
1LigandsIBA
01/2017
1Surface Antigens (Surface Antigen)IBA
04/2016
1Hepatitis B Surface Antigens (HBsAg)FDA Link
04/2016
1Antisense OligonucleotidesIBA
04/2016
1Lamivudine (Epivir)FDA Link
02/2015
1GSK2336805IBA
07/2014
1Boronic AcidsIBA
03/2014
1Polysaccharides (Glycans)IBA
07/2012
1BrassinosteroidsIBA
07/2012
1Immunoglobulin G (IgG)IBA
03/2010

Therapy/Procedure

12Therapeutics
03/2024 - 01/2002
1Jejunoileal Bypass
10/2021
1Thrombolytic Therapy
06/2021
1Drug Therapy (Chemotherapy)
07/2020
1Adrenalectomy
07/2019
1Blood Transfusion (Blood Transfusions)
01/2017